TOP医療従事者の皆さまへ研究・業績(論文一覧)>2017年
医療従事者の皆さまへ
患者・ご家族の皆さまへ
医療従事者の皆さまへ
学生・研修医の皆さまへ

シンボルマーク

研究・業績(論文一覧) 2017年

英語論文邦文総説・著書邦文原著邦文その他
【英語論文】
  1. Kubo T, Hirohashi Y, Matsuo K, Sonoda T, Sakamoto H, Furumura K, Tsukahara T, Kanaseki T, Nakatsugawa M, Hirano H, Furuhata T, Takemasa I, Hasegawa T, Torigoe T., Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative "Adaptive Immune Escape" Phenomenon., Anticancer Res., 37, 3, 1289-1295, 2017, 3
  2. Miyo M, Takemasa I, Ikeda M, Tujie M, Hasegawa J, Ohue M, Kato T, Mizushima T, Doki Y, Mori M., The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity., Surg Today, 2017, 3
  3. Miyo M, Konno M,Colvin H,Nishida N,Koseki J,Kawamoto K, Tsunekuni K,Nishimura J,Hata T,Takemasa I,Mizushima T,Doki Y,Mori M,Ishii H, The importance of mitochondrial folate enzymes in human colorectal cancer., Oncol Rep, 37, 1, 417-425, 2017, 1
  4. Yasui M, Ikeda M,Miyake M,Lde Y,Okuyama M,Shingai T,Kitani K,Ikenaga M,Hasegawa J,Akamatsu H,Murata K,Takemasa I,Mizushima T,Yamamoto H,Sekimoto M,Nezu R,Doki Y,Mori M;Clinical Study Group of Osaka University(CSGO),Colorectal Group, Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients., Am J Surg, 213, 1, 43-49, 2017, 1
  5. Yamamoto I, Nosho K,Kanno S,Igarashi H,zkurihara H,Ishigami K,Ishiguro K,Mitsuhashi K,Maruyama R,Koide H,Okuda H,Hasegawa T,Sukawa YOkita K,Takemasa I,Yamamoto H,Shinomura Y,Nakase H, EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics., Oncotarget, 8, 11, 17810-17818, 2017, 3
  6. Kanazaki R, Inoue M,Kimura T,Kawamura T,Funaki S,Shintani Y,Minami M,Takemasa I,Mizushima T,Mori M,Okumura M, Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy., Surg Today, 2017, 2
  7. Takemoto H, Nishimura J,Komori T,Kim HM,Ota H,Suzuki R,Ikenaga M,Ikeda M,Yamamoto H,Satoh T,Hata T,Takemasa I,Mizushima T,Doki Y,Mori M,Multicenter Clinical Study Group of Osaka,Colorectal Cancer Treatment Group, Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea., Int J Clin Oncol, 22, 1, 88-95, 2017, 2
  8. Hata T, Mizushima T,Osawa H,Takahashi H,Haraguchi N,Nishimura J, Hata T,Takemasa I,Ikenaga M,Nakajima K,Yamamoto H,Murata K, Doki Y,Mori M, Short-term outcomes of laparoscopic surgery for Crohn's disease patients treated with anti-tumor necrosis factor alpha agents., Surg Today, 47, 3, 320-327, 2017, 3
  9. Osawa H, Takahashi H, Nishimura J, Ohta K, Haraguchi N, Hata T, Yamamoto H, Mizushima T, Takemasa I, Doki Y, Mori M., Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer., Br J Cancer, 114, 11, 1251-1260, 2016, 5
  10. Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I., SOX2 and ALDH1 as Predictors of Operable Breast Cancer., Anticancer Res, 36, 6, 2945-2953, 2016, 6
  11. Yamamoto H, Murata K, Fukunaga M, Ohnishi T, Noura S, Miyake Y, Kato T, Ohtsuka M, Nakamura Y, Takemasa I, Mizushima T, Ikeda M, Ohue M, Sekimoto M, Nezu R, Matsuura N, Monden M, Doki Y, Mori M., Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial, Clin Cancer Res, 22, 13, 3201-3208, 2016, 7
  12. Mizushima T, Takahashi H, Takeyama H, Naito A, Haraguchi N, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M., A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula., Surg Today, 46, 7, 835-842, 2016, 7
  13. Takaya A, Hirohashi Y,Murai A,Morita R,Saijo H,Yamamoto E,Kubo T, Nakatsugawa M,Kanaseki T,Tsukahara T,Tamura Y,Takemasa I, Kondo T,Sato N,Torigoe T, Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480., PLoS One, 11, 7, e0158903, 2016, 7
  14. Hamabe A, Takemasa I,Hata T,Mizushima T,Doki Y,Mori M, Patient Body Image and Satisfaction with Surgical Wound Appearance After Reduced Port Surgery for Colorectal Diseases., World J Surg, 40, 7, 1748-1754, 2016, 7
  15. Uemura M, Kim HM,Hata T,Sakata K,Okuyama M,Takemoto H,Fukuzaki T, Morita T,Hata T,Takemasa I,Satoh T,Mizushima T,Doki Y,Mori M; Multicenter Clinical Study Group of Osaka,Colorectal Cancer Treatment Group(MCSGO), First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer., Mol Clin Oncol, 5, 2, 375-379, 2016, 8
  16. Uemura M, Kim HM,Ikeda M,Nishimura J,Hata T,Takemasa I, Mizushima T, Yamamoto H,Doki Y,Mori M, Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases., Oncol Lett, 12, 3, 1649-1654, 2016, 9
  17. Maeda H, Kutomi G,Satomi F,Shima H,Mori M,Hirata K,Takemasa I, Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration., Exp Ther Med, 12, 4, 2766-2772, 2016, 10
  18. Nishimura J, Hasegawa J,Ogawa Y,Miwa H,Uemura M,Haraguchi N,Hata T, Yamamoto H,Takemasa I,Mizushima T,Nezu R,Doki Y,Mori M, (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer., Surg Today, 46, 10, 1152-1158, 2016, 10
  19. Munakata K, Uemura M, Tanaka S, Kawai K, Kitahara T, Miyo M, Kano Y, Nishikawa S, Fukusumi T, Takahashi Y, Hata T, Nishimura J, Takemasa I, Mizushima T, Ikenaga M, Kato T, Murata K, Carethers JM, Yamamoto H, Doki Y, Mori M., Cancer stem-like properties in colorectal cancer cells with low proteasome activity., Clin Cancer Res, 22, 21, 5277-5286, 2016, 11
  20. Yamamoto H, Oshiro R, Ohtsuka M,Uemura M,Haraguchi N,Nishimura J, Takemasa I, Mizushima T,Doki Y,Mori M, [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies., Int J Oncol, 49, 5, 2186, 2016, 11
  21. Akita H, Ritchie SA,Takemasa I,Eguchi H,Pastural E,Jin W,Yamazaki Y, Goodenowe DB,Nagano H,Monden M,Mori M,Doki Y, Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study., Pancreas, 45, 10, 1418-1423, 2016, 11
  22. Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 2, 1, 54, 2016, 12
  23. Takahashi H, Takemasa I, Haraguchi N, Nishimura J, Hata T,Yamamoto H,Matsuda C, Mizushima T, Doki Y,Mari M, The single-center experience with the standardization of single-site laparoscopic colectomy for right-sided colon cancer., Surg Today, 2016, 12
  24. Mokutani Y, Uemura M,Munakata K,Okuzaki D,Haraguchi N,Takahashi H, Nishimura J,Hata T,Murata K,Takemasa I,Mizushima T,Doki Y, Mori M,Yamamoto H, Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer., Ann Surg Oncol, 23, 5, 599-608, 2016, 12
  25. Ichinohe N, Ishii M, Tanimizu N, Kon J, Yoshioka Y, Ochiya T, Mizuguchi T, Hirata K, Mitaka T. , Transplantation of Thy1+ Cells Accelerates Liver Regeneration by Enhancing the Growth of Small Hepatocyte-like Progenitor Cells via IL17RB Signaling. , Stem Cells., 34, 12, 920-931, 2017
  26. Tanimizu N, Ichinohe N, Ishii M, Kino J, Mizuguchi T, Hirata K, Mitaka T, Liver progenitors isolated from adult healthy mouse liver efficiently differentiate to functional hepatocytes in vitro and repopulate liver tissue., Stem Cells., 34, 12, 2889-2901, 2016
  27. Tanimizu N, Kaneko K, Itoh T, Ichinohe N, Ishii M, Mizuguchi T, Hirata K, Miyajima A, Mitaka T., Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement., Hepatology., 64, 1, 175-88, 2016
  28. Kinoshita M, Kubo S, Nakanuma Y, Sato Y, Takemura S, Tanaka S, Hamano G, Ito T, Terajima H, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Sugawara Y, Yamamoto T, Abue M, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Shirabe K, and Shibata T:, Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma., J Hepatobiliary Pancreat Sci., 23, 92-101, 2016
  29. Nagayama M, Mizuguchi T, Yamaguchi H, Imamura M, Kutomi G, Okita K, Nishidate T, Takemasa I, Kimura Y., Technical aspects and surgical complications of laparoscopic liver resection. , Ann Laparosc Endosc Surg, 2, 61, 2017
  30. Nakao H, Wakai K, Ishii N, Kobayashi Y, Ito K, Yoneda M, Mori M, Nojima M, Kimura Y, Endo T, Matsuyama M, Ishii H, Ueno M, Kuruma S, Egawa N, Matsuo K, Hosono S, Ohkawa S, Nakamura K, Tamakoshi A, Takahashi M, Shimada K, Nishiyama T, Kikuchi S, Lin Y, Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects:, BMC Gastroenterology, 16, 1, 2016, doi: 10.1186/s12876-016-0503-7.
  31. Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 2, 1, 54, 2016, doi: 10.1186/s40792-016-0181-2. Epub 2016 Jun 3.
  32. Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K, Current status of the prognostic molecular biomarkers in breast cancer: A systematic review, Oncology Letters, doi: 10.3892/ol.2017.5609.3892/ol.2017.5609
  33. Kanno S, Nosho K, Ishigami K, Yamamoto I, Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S, Tanuma T, Maguchi H, Hasegawa T, Kimura Y, Takemasa I, Shinomura Y, Nakase H. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer., Carcinogenesis., 2017
  34. Ota S, Nishimura M, Murakami Y, Birukawa NK, Yoneda A, Nishita H, Fujita R, Sato Y, Minomi K, Kajiwara K, Miyazaki M, Uchiumi M, Mikuni S, Tamura Y, Mizuguchi T, Imamura M, Meguro M, Kimura Y, Hirata K, Niitsu Y., Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy., PLoS One., 41616, 11(12), e0165747, 2016, doi: 10.1371/journal.pone.0165747
  35. Ito T, Honma Y, Hijioka S, Kudo A, Fukutomi A, Nozaki A, Kimura Y, Motoi F, Isayama H, Komoto I, Hisamatsu S, Nakajima A, Shimatsu A., Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors., Invest New Drugs., 2017 May 3., 10.1007/s10637-017-0466-8.
  36. Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T, Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study., Gastric Cancer, 20, 3, 517-526, 2017
  37. Kubo T, Kawano Y, Himuro N, Sugita S, Sato Y, Ishikawa K, Takada K, Murase K, Miyanishi K, Sato T, Takimoto R, Kobune M, Nobuoka T, Hirata K, Takayama T, Mori M, Hasegawa T, Kato J., BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer., Gastric Cancer, 19, 3, 827-838, 2016
  38. Shinya Chihara, Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock, J Artif Organs, Epub ahead of print, 2016
  39. Satoshi Kazuma, Yoshiki Masuda, Hiroomi Tatsumi, Kanako Takahashi, Shinichiro Yoshida, Maiko Honma, Hitoshi Imaizumi, Michiaki Yamakage, Almost Total Airway Obstruction Due to Unidentified Massive Hemoptysis under Extracorporeal Membrane Oxygenation, Int J Crit Care Emerg Med, 2, 1, 012, 2016
  40. Morita R, Hirohashi Y, Torigoe T, Ito-Inoda , Takahashi A, Mariya T, Asanuma H, Tamura Y, Tsukahara T, Kanaseki T, Kubo T, Kutomi G, Mizuguchi T, Terui T, Ishitani K, Hashino S, Kondo T, Minagawa N, Takahashi N, Taketomi A, Todo S, Asaka M, Sato N, Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy., Clin Cancer Res, 41455. 22, 3298-309, 2016
  41. Jinno H, Inokuchi M, Ito T, Kitamura K, Kutomi G, Sakai T, Kijima Y, Wada N, Ito Y, Mukai H, The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition., Breast Cancer, May, 23, 367-77, 2016
  42. Tanabe A, Tanikawa K, Tsunetomi M, Takai K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, Mori M, Sahara H., RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated, Cancer Lett, 41452, 376, 34-42, 2016
  43. Tanaka T, Kutomi G, Kajiwara T, Kukita K, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Okamoto Y, Hirata K, Sato N, Tamura Y, Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level, Br J Cancer, 41417, 114, 1227-34, 2016
  44. Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I., Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep, 41609, 54, 2016
  45. Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I, SOX2 and ALDH1 as Predictors of Operable Breast Cancer., Anticancer Res, Jun, 36, 2945-53, 2016
  46. Maeda H, Kutomi G, Satomi F, Shima H, Mori M, Hirata K, Takemasa I, Clinicopathological characteristics of thyroid cancer misdiagnosed by fine needle aspiration., Exp Ther Med, Oct, 12, 2766-2772, 2016
  47. Kutomi G, Mizuguchi T, Satomi F, Maeda H, Shima H, Kimura Y, Hirata K, Current status of the prognostic molecular biomarkers in breast cancer: A systematic review., Oncol Lett, Mar, 13, 1491-1498, 2017
  48. Kajiwara T, Tanaka T, Kukita K, Kutomi G, Saito K, Okuya K, Takaya A, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Hirata K, Sato N, Tamura Y., Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells., Eur J Immunol, Dec, 46, 2842-2851, 2016
  49. Bunta N, Sawamoto K, Uemura S, Toyohara T, Mori Y, Kyan R, Miyata K, Irifune H, Harada K, Narimatsu E., How to manage Tension gastrothorax: A case report of tension gastrothorax with multiple trauma due to traumatic diaphragmatic rupture., International Journal of Emergency Medicine, 2017
  50. Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H., EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics., Oncotarget, 8, 11, 17810-8, 2017
  51. Tanabe A, Tanikawa K, Tsunetomi M, Takai K, Ikeda H, Konno J, Torigoe T, Maeda H, Kutomi G, Okita K, Mori M, Sahara H., RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated., Cancer Lett., 376, 1, 34-42, 2016
  52. Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K., The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway., Oncotarget, 7, 11, 12704-17, 2016
  53. Shima H, Kutomi G, Satomi F, Maeda H, Hirohashi Y, Hasegawa T, Mori M, Torigoe T, Takemasa I, SOX2 and ALDH1 as predictors of operable breast cancder, Anticancer Res., 36, 6, 2945-53, 2016
  54. Shima H, Kutomi G, Kyuno T, Satomi F, Uno S, Maeda H, Kameshima H, Omura T, Kimura Y, Mizuguchi T, Hirata K, Takemasa I, Flap revascularization in patients following immediate reconstruction using an autologous free dermal fat graft for breast cancer: a report of two cases., Surg Case Rep., 2, 1, 54, 2016
  55. Mizuguchi T, Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, Ishii M, Hayashi, H, Asakura S, Hirohashi Y, Meguro M, Kimura Y, Nishidate T, Okita K, Ishino M, Miyamoto A, Hatakenaka M, Sato N, Hirata K., Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?, Surg Today, 46, 2, 139-148, 2016
  56. Kobayashi K, Sumikawa Y, Kikuchi Y, Kan Y, Kato J, Satomi F, Shima H, Kutomi, G, Yamashita T. Synchronous Paget disease of the breast and axilla., Synchronous Paget disease of the breast and axilla., J Am Acad Dermatol, 72, 1, e44-45, 2016
  57. Kutomi G, Ohmura T, Satomi F, Maeda H, Shima H, Kameshima H, Okazaki M, Masuoka H, Sasaki K, Hirata K., A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer., Int J Clin Oncol, 20, 3, 474-479, 2015
  58. Yasunori Matsumoto, Masayuki Kano, Yasunori Akutsu, Naoyuki Hanari, Isamu Hoshino, Kentaro Murakami, Akihiro Usui, Hiroshi Suito, Masahiko Takahashi, Ryota Otsuka, Hu Xin, Aki Komatsu, Keiko Iida, and Hisahiro Matsubara, Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma., Oncology report, 36, 5, 2535-2543, 2016
  59. Toyozumi T, Hoshino I, Takahashi M, Usui A, Akutsu Y, Hanari N, Murakami K, Kano M, Akanuma N, Suitoh H, Matsumoto Y, Sekino N, Komatsu A, Matsubara H., Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma., Annals of surgical oncology, 2016

▲ページTOPへ
【邦文総説・著書】
  1. 竹政伊知朗, 腹腔鏡下大腸癌手術 解剖学に基づいた視野展開について-カウンタートラクション, 臨床外科, 71, 31, 1479-1482, 2016, 12
  2. 西舘敏彦, 竹政伊知朗, 術後ドレーン留置部位まるわかりノート, 消化器外科Nursing, 21, 6, 498-509, 2016, 6
  3. 竹政伊知朗, 腹腔鏡下側方リンパ節郭清術, 消化器外科, 39, 5, 665-673, 2016, 4
  4. 木村康利, 今村将史、永山 稔、目黒 誠、山口洋志、河野 剛、水口 徹、竹政伊知朗, 急性胆嚢炎、胆管炎に対する外科治療, 最新医学, ABC121「胆石症・胆管結石・胆道炎・胆道がん」, 最新医学社, 111-118, 2017
  5. 水口 徹, 木村康利, 腹腔鏡下肝部分切除術, 消化器外科, 39, 5, 773-781, 2016
  6. 木村康利, 竹政伊知朗, 第5章 手術 最新トピックス:膵体尾部切除術の断端処理, 新世代の膵癌診療・治療バイブル」, 2017
  7. 萩原 誠也, 林 毅, 種田 紳二, 木村 康利, 長谷川 匡, 三澤 和史, 土田 健一, 名和 伴恭, 中野 玲奈, 坂東 秀訓, 中山 秀隆, 萬田 直紀, 2型糖尿病の治療経過中に診断された膵管内乳頭粘液性腺癌の1例, 糖尿病と代謝, 44, 1, 16-20, 2016
  8. 日本集中治療医学会重症患者の栄養管理ガイドライン作成委員会, 小谷穣治、江木盛時、海塚安郎、亀井有子、神應知道、木下浩作、佐藤格夫、清水孝宏、清水義之、志馬伸朗、白井邦博、巽 博臣、西田 修、東別府直紀、松田兼一、真弓俊彦、平澤博之、氏家良人, 日本版重症患者の栄養療法ガイドライン, 日集中医誌, 23, 2, 185-281, 2016
  9. 巽 博臣, 升田好樹、高橋科那子, クリティカルケアにおけるAKIの管理.I.AKIの管理に必要な基礎知識~AKIの全体像を捉える~.AKIの予防と治療 ④栄養管理~何を増やして、何を控える!?~., 重症患者ケア, 5, 2, 182-189, 2016
  10. 佐藤格夫, 神應知道、巽 博臣、白井邦博、海塚安郎、西田 修, 特集 日本集中治療医学会重症患者の栄養療法ガイドラインをめぐって.特殊栄養素., ICUとCCU, 40, 6, 417-424, 2016
  11. 巽 博臣, 升田好樹、高橋科那子, 急性腸管不全の病態・診断トピックス.各論V;急性腸管不全.特集 急性臓器障害 注目の診断・治療トピックス., 救急医, 40, 8, 937-942, 2016
  12. 升田好樹, 巽 博臣、高橋科那子, 特集 輸液―急性期を立て直す.各論 高齢者における急性期輸液の実際., 救急医, 40, 13, 1685-1694, 2016
  13. 巽 博臣, 升田好樹, 特集 重症病態における栄養管理.急性腎障害., 外科と代謝・栄, 50, 6, 335-339, 2016
  14. 巽 博臣, 特集 話題の最新トピックス.だからナースはこうする! 2 重症患者では静脈栄養より経腸栄養を優先する., エキスパートナース, 33, 2, 31-34, 2017
  15. 巽 博臣, 特集 話題の最新トピックス.だからナースはこうする! 3 重症患者は血糖値180mg/dL以下。測定間隔は4時間以内., エキスパートナース, 33, 2, 35-38, 2017
  16. 巽 博臣, 特集1 何を・いつから・どこから入れるの?をスッキリ解決 栄養療法のこれがベスト・セレクト.Part 2 病態・状況に応じた これが栄養療法のベスト・セレクト.1.急性・重症患者 経腸栄養の選択と早期開始の推奨、その根拠., 月刊ナーシング, 37, 3, 21-25, 2017
  17. 荒川朋子, 巽 博臣, 特集1 何を・いつから・どこから入れるの?をスッキリ解決 栄養療法のこれがベスト・セレクト.Part 2 病態・状況に応じた これが栄養療法のベスト・セレクト.5.褥瘡(リスク)のある患者 創傷治癒を促進する栄養管理の実際., 月刊ナーシング, 37, 3, 40-43, 2017
  18. 橋場貴恵, 巽 博臣, 特集1 合併症を予防し、安全なケアの実践! 現場の疑問をエキスパートが解決! 急性期看護でのベッドサイドケア~循環動態が不安定な患者をどうケアするか.排便ケア., 呼吸・循環ケア, 38, 2, 28-35, 2017
  19. 増岡 秀次, 九冨 五郎, 三神 俊彦, 桜井 美紀, 藤澤 純子, 吉田 佳代, 白井 秀明, 下川原 出, 浅石 和昭, 島 宏彰, 前田 豪樹, 大村 東生, 亀嶋 秀和, 三原 大佳, 野村 直弘, 森 満, "受けてよかった乳がん検診"にするための工夫 精査施設における乳がん検診 診断から治療まで, 日本乳癌検診学会誌, 25, 1, 20-26, 2016
  20. 秋月恵美, 栄養管理のこれがベストセレクト;周術期の患者, 月刊ナーシング, 37, 3, 26-30, 2017

▲ページTOPへ
【邦文原著】
  1. 髙橋科那子, 升田好樹、巽 博臣、吉田真一郎、数馬 聡、後藤京子、今泉 均、山蔭道明, ICUにおける治療抵抗性体液過剰症例に対するトルバプタンの有効性に関する検討, ICUとCCU, 40, 3, 231-236, 2016
  2. 増岡 秀次, 九冨 五郎, 三神 俊彦, 藤澤 純子, 桜井 美紀, 吉田 佳代, 白井 秀明, 下川原 出, 浅石 和昭, 島 宏彰, 前田 豪樹, 大村 東生, 亀嶋 秀和, 三原 大佳, 野村 直弘, 森 満, ハイリスク女性に対する検診をどうするか ハイリスク女性に対する検診の勧奨, 日本乳癌検診学会誌, 24, 2, 215-222, 2015
  3. 碓井 彰大, 阿久津 泰典, 河野 世章, 上里 昌也, 村上 健太郎, 太田 拓実, 羽成 直行, 加野 将之, 松本 泰典, 高橋 理彦, 水藤 広, 大塚 亮太, 松原 久裕, 食道アカラシア術後再発に対して腹腔鏡下根治術を施行した1例, 千葉医学雑誌, 92, 5, 189-192, 2016

▲ページTOPへ
【邦文その他】
  1. 信岡隆幸, 一般社団法人日本静脈経腸栄養学会, 静脈経腸栄養テキストブック, 南江堂, 2017
  2. 名和由布子, 升田好樹、巽 博臣、杉山由紀、後藤京子、要藤裕孝、今泉 均、山蔭道明, 急激に発症した代謝性アシドーシスに対し持続血液浄化療法施行直後から改善がみられた1小児例, 日集中医誌, 23, 3, 345-346, 2016
  3. 巽 博臣, 升田好樹、髙橋科那子、本間舞子、数馬 聡、片山洋一、吉田真一郎, ガス貯留を伴う巨大な感染性下大静脈血栓による敗血症性ショック・DICの1救命例, 日救命医療会誌, 30, 1, 7-12, 2016
  4. 九冨 五郎, 久木田 和晴, 里見 蕗乃, 前田 豪樹, 島 宏彰, 水口 徹, 平田 公一, バイオマーカーをめぐるQ&A(Question 16) hERO1-Lα発現による乳癌予後予測は可能か?, Surgery Frontier, 22, 3, 283-285, 2015
  5. 里吉哲太, 青山徹、渥美陽介、風間慶祐、村川正明、山奥公一郎、森本学、塩澤学、吉川貴己、森本聡一郎, 切除不能な十二指腸GISTに対し術前Imatinib療法が奏効し根治手術を施行した1例, 日本外科系連合学会誌, 4, 6, 949-954, 2016

▲ページTOPへ